SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 5 of 100
Health
Will AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?
By
Sy Mukherjee
Health
Hispanics are twice as eager to get COVID vaccines as white people. Actually getting them is the hard part
By
Sy Mukherjee
Newsletters
2021’s greatest health care leaders
By
Sy Mukherjee
Health
How a curious, well-informed army of children could propel the COVID vaccination campaign
By
Sy Mukherjee
Health
COVID vaccine IP waivers won’t ‘solve any immediate problem’
By
Sy Mukherjee
Newsletters
Can a single number paint an accurate picture of health? This company thinks it can
By
Sy Mukherjee
Health
The COVID vaccine is set to make up more than half of Pfizer’s 2021 revenue
By
Sy Mukherjee
Health
We probably won’t reach COVID herd immunity. So why are states already re-opening?
By
Sy Mukherjee
Newsletters
Will menthol cigarettes finally be tossed into the dustbin of history?
By
Sy Mukherjee
Health
T-shirts, bonuses, and paid time off: How companies are incentivizing workers to get a COVID vaccine as new guidance looms
By
Sy Mukherjee
Newsletters
Health care’s access dilemma and lessons from Brainstorm Health
By
Sy Mukherjee
and
Marco Quiroz-Gutierrez
Newsletters
Inequities of health care past and inequities of health care present
By
Sy Mukherjee
Conferences
Black men’s enrollment in medical school isn’t improving
By
Sy Mukherjee
Conferences
Gilead’s remdesivir is now used to treat half of hospitalized COVID patients
By
Sy Mukherjee
Newsletters
What the front lines of the vaccine rollout are really like, according to health leaders
By
Sy Mukherjee
and
Erika Fry